- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04578418
Effect of Collagen Supplementation on Tendinopathy
January 14, 2021 updated by: Kasper Dideriksen, Bispebjerg Hospital
Effect of Collagen Supplementation on Tendinopathy in Elite Athletes
Tendon injuries represent a significant problem in elite athletes.
Therefore, prevention and effective treatment of tendon overload injury/tendinopathy is important.
Among different treatment options, heavy-slow loading based rehabilitation is considered among the most efficient treatments in athletes.
In this study, we will investigate if supplementation with hydrolyzed collagen in combination with a heavy-slow loading based 12 weeks rehabilitation regime can improve treatment of tendon overload injury/tendinopathy.
The investigators will examine elite athletes with overload injury/tendinopathy with regards to symptoms (pain, function), tendon morphology (ultrasonography), and vascularization (Doppler US).
The investigators hypothesize that collagen supplementation can have an improving effect on tendon pain and function.
Thus, the investigation will show if a rehabilitation regime of collagen supplementation combined with heavy-slow mechanical loading can improve tendon healing compared to mechanical loading alone.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Randomized placebo-controlled intervention study with follow-up after one month
Study Type
Interventional
Enrollment (Anticipated)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kasper Dideriksen, PhD
- Phone Number: +4524251989
- Email: kasperjuel@hotmail.com
Study Contact Backup
- Name: Christian Couppé, PhD
- Phone Number: +4560660825
- Email: christian.couppe@regionh.dk
Study Locations
-
-
-
Copenhagen NV, Denmark, 2400
- Recruiting
- Department of Physical and Occupational Therapy/Institute of Sports Medicine Copenhagen, Bispebjerg Hospital
-
Contact:
- Christian Couppé, PhD
- Phone Number: 60660825
- Email: christian.couppe@regionh.dk
-
Principal Investigator:
- Christian Couppé, PhD
-
Principal Investigator:
- Kasper Dideriksen, PhD
-
Principal Investigator:
- Christoffer Brushøj, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 38 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Elite athletes
- 18-40 years old
- Exercise related tendon pain on one or both legs
- Soreness during physical examination of tendon upon palpation
- Uni- or bilateral tendinopathy symptoms > 3 months
Exclusion Criteria:
- Previous tendon surgery
- Diabetes
- Arthritis
- Corticosteroid injection for tendinopathy within the last 3 months
- Any form of tendon injection within the last 3 months
- Smoking
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Collagen + heavy slow resistance group
Daily collagen supplementation + heavy slow resistance training three times weekly for 12 weeks.
|
Hydrolyzed collagen supplementation twice daily
Heavy slow resistance training 3 times weekly
|
Experimental: Placebo + heavy slow resistance group
Daily placebo supplementation + heavy slow resistance training three times weekly for 12 weeks.
|
Heavy slow resistance training 3 times weekly
Placebo supplementation twice daily
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximal tendon pain during the past week at preferred sporting activity
Time Frame: Baseline-12 weeks
|
Change from baseline - 12 weeks using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)
|
Baseline-12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximal tendon pain during the past week at preferred sporting activity
Time Frame: Baseline, 6 weeks + 6 month follow-up
|
Change from baseline - 6 weeks + 1 month follow-up using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)
|
Baseline, 6 weeks + 6 month follow-up
|
Self-reported activity level of sporting activities (hours/week)
Time Frame: Baseline, 6 and 12 weeks + 6 month follow-up
|
Participants will self-report how many hours a week they are performing sporting activities: We will monitor to see if they decrease, maintain or increase hours per week of sporting activity
|
Baseline, 6 and 12 weeks + 6 month follow-up
|
Single-leg decline squat (SLDS) test
Time Frame: Baseline - 12 weeks
|
A reliable patellar tendon pain provocation test, will be used to assess pain during function using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)
|
Baseline - 12 weeks
|
Jump test
Time Frame: Baseline - 12 weeks
|
A reliable Achilles/Plantaris tendon pain provocation test, will be used to assess pain during function using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)
|
Baseline - 12 weeks
|
Treatment satisfaction
Time Frame: 12 weeks
|
Participants will be asked after the intervention period whether they were satisfied or not with the treatment (dichotom : Yes vs. No)
|
12 weeks
|
Collagen supplement
Time Frame: Baseline - 12 weeks + 6 month follow-up
|
Participants will be asked on a weekly basis if taken their collagen supplement : Questionnaire (dichotom : Yes vs. No)
|
Baseline - 12 weeks + 6 month follow-up
|
Adverse events (e.g. allergies, gastro-intestinal side effects) related to supplement ingestion
Time Frame: Baseline - 12 weeks + 6 month follow-up
|
Participants will self-report adverse events during intervention period and at 6 month follow-up
|
Baseline - 12 weeks + 6 month follow-up
|
Return-to-sport activities
Time Frame: Baseline - 12 weeks + 6 month follow-up
|
Participants will self-report Return-to-sport activities during intervention period and at 6 month follow-up (dichotom : Yes vs. No)
|
Baseline - 12 weeks + 6 month follow-up
|
Change from baseline Victorian Institute of Sports Assessment - Patella/Achilles Questionnaire (VISA-P/A) at 12 wks
Time Frame: Baseline, 6 and 12 weeks + 6 month follow-up
|
Patient reported outcome regarding symptoms, function and the ability to participate in sports
|
Baseline, 6 and 12 weeks + 6 month follow-up
|
Change from baseline Foot function index - Plantaris questionnaire at 12 wks
Time Frame: Baseline, 6 and 12 weeks + 6 month follow-up
|
Patient reported outcome regarding symptoms, function and the ability to participate in sports
|
Baseline, 6 and 12 weeks + 6 month follow-up
|
Tendon Doppler activity using Ultrasonography power Doppler
Time Frame: Baseline - 12 weeks
|
Using Ultrasonography, we will measure Doppler activity within the affected tendon and use ImageJ for the analysis
|
Baseline - 12 weeks
|
Tendon thickness measured using Ultrasonography
Time Frame: Baseline - 12 weeks
|
Baseline - 12 weeks
|
|
Pain rating on Numeric Rating Scale (NRS; 0 = no pain; 10 = worst imaginable pain) during training.
Time Frame: Baseline, 6 and 12 weeks + 6 month follow-up
|
Baseline, 6 and 12 weeks + 6 month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Christian Couppé, PhD, Institute of Sports Medicine
- Principal Investigator: Kasper Dideriksen, PhD, Team Denmark
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 16, 2020
Primary Completion (Anticipated)
January 1, 2023
Study Completion (Anticipated)
June 1, 2023
Study Registration Dates
First Submitted
September 15, 2020
First Submitted That Met QC Criteria
October 1, 2020
First Posted (Actual)
October 8, 2020
Study Record Updates
Last Update Posted (Actual)
January 19, 2021
Last Update Submitted That Met QC Criteria
January 14, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-16019857
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tendinopathy
-
University of CadizNot yet recruitingTendinopathy | Achilles Tendinopathy | Tendinopathy, Elbow | Patellar Tendinopathy | Tendinopathy Rotator CuffSpain
-
University of CalgarySport Science Association of Alberta (SSAA)UnknownAchilles Tendinopathy | Achilles Tendon Enthesopathy | Mid-Portion Achilles Tendinopathy | Insertional Achilles Tendinopathy | Non-Insertional Achilles TendinopathyCanada
-
Krankenhaus Barmherzige Schwestern LinzActive, not recruitingAchilles Tendinopathy | Insertional Achilles TendinopathyAustria
-
Brooke Army Medical CenterRecruitingLateral Elbow TendinopathyUnited States
-
Guna S.p.aRecruitingTendinopathy | Achilles Tendinopathy | Insertional Achilles Tendinopathy | PeritendinitisItaly
-
Elif Balevi BaturCompleted
-
Anika Therapeutics, Inc.Completed
-
University of DelawareRecruitingSever's Disease | Achilles Tendinopathy | Insertional Achilles Tendinopathy | Apophysitis; CalcaneusUnited States
-
Musculoskeletal Injury Rehabilitation Research...The Geneva Foundation; Fort Belvoir Community HospitalRecruitingAchilles TendinopathyUnited States
-
Gelderse Vallei HospitalRecruiting
Clinical Trials on Hydrolyzed collagen
-
Sel Sanayi Urunleri Ticaret ve Pazarlama A.S.Alpan Farma Ar-Ge Biyoteknolojileri Ltd.Sti.Not yet recruiting
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...RecruitingPlantar FascitisItaly
-
Nealth SarlROUSSELOT SASCompleted
-
Liverpool John Moores UniversityCompletedExercise Training | Healthy Participants | NutritionUnited Kingdom
-
Hofseth Biocare ASAMøre og Romsdal Hospital TrustCompletedOsteoarthritis | Osteoarthritis, Knee | Osteoarthritis, HipNorway
-
University of California, DavisCompleted
-
Rob ErskineUniversity of East AngliaCompletedDiet, Food, and NutritionUnited Kingdom
-
Rob ErskineUniversity of East AngliaCompletedDiet | Nutrition | FoodUnited Kingdom
-
Francisco Jose Rodriguez VelascoNutraResearch, SLCompleted
-
Abbott NutritionTerminatedCow's Milk AllergyUnited States